| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 22, 2025 | Plural Investing | 21.9% | 3.8% | JDG.L, WOSG.L | Luxury, retail, Scientific Instruments, small caps, Uk, value | The fund focuses on businesses trading at substantial discounts to conservatively calculated intrinsic value. Portfolio trades at 9.0x FCF in three years with businesses earning 23% post-tax return on capital. Manager emphasizes only investing in businesses worth substantially more than their trading price. | WOSG.L JDG.L JDG LN WOSG LN JET2 LN |
View |
| 2024 Q2 | Jul 1, 2024 | REQ Global Compounders | - | 14.0% | ATCO-A.ST, BEIJ-B.ST, BERG-B.ST, CSU.TO, DPLM.L, ELUX-B.ST, ERIC-B.ST, IMCD.AS, INDU-A.ST, JDG.L, LAGR.ST, LIFCO-B.ST, MEDC.ST, NIBE-B.ST, SAND.ST | Acquisitions, B2B, Compounding, Decentralization, Industrial, Sweden | REQ emphasizes decentralized organizational structures as a core investment pillar, where management delegates responsibility down the organization. This approach enables companies to maintain entrepreneurial agility while scaling, with decision-makers close to customers and lean corporate headquarters. | View | |
| 2024 Q1 | May 9, 2024 | Polen Capital – Global SMID Company Growth | 7.4% | -2.4% | 3697.T, 8069.TWO, CNM, CWAN, DAVA, EVD.L, FEVR.L, GLOB, JDG.L, PME.AX, REVG, TOI.TO, WIZZ.L | global, growth, infrastructure, IT Services, Quality, SMID Cap, software | The portfolio holds multiple IT services companies including Globant and Endava, both facing headwinds from cautious client spending on digital transformation. Despite near-term challenges, the managers maintain confidence in long-term secular trends driving digital transformation and AI integration. | 3697.T DAVA GLOB CNM EVD.DE TOI.TO |
View |
| 2026 Q1 | Apr 28, 2026 | Plural Investing | -11.6% | -11.6% | JDG.L, JET2.L, PLOW | Acquisitions, industrials, small caps, Travel, Uk, value | JDG.L PLOW |
View | |
| 2023 Q3 | Oct 31, 2023 | MCJ Capital Partners | 10.6% | 11.7% | CPRT, CSU.TO, JDG.L, KSI.TO, KUT.V | international, Patience, Process, small caps, value | Portfolio is primarily made up of smaller companies trading at historically cheap levels relative to large-cap counterparts. Only during the dotcom bubble has small been cheaper on a relative basis to large-cap stocks. Manager views this as an opportunity in unbeloved asset groups pushed to cheapest levels in recent history. | KSI.TO JDG.L KUT.V CSU.TO |
View |
| 2025 Q3 | Oct 30, 2025 | Church House Human Capital | -4.6% | - | 9424.T, BERG-B.ST, CHAP.DE, CICN.SW, CSU.TO, DPLM.L, INDU.ST, JDG.L, KPG.AX, LAGR-B.ST, LIFCO-B.ST, LMN.TO, MGRP.ST, PMS, SIS.TO, TOI.TO | Acquisitive, Decentralised, global, Mid-cap, small caps, value | The fund focuses on entrepreneurial, acquisitive, decentralised businesses that are being overlooked as markets remain fixated on the Magnificent Seven. The manager sees this as creating opportunities in smaller companies with strong fundamentals. | View | |
| 2025 Q3 | Oct 21, 2025 | Plural Investing | -9.1% | -5.6% | GLIB.A, JDG.L, JET2.L, SEG, WOSG.L | Buybacks, Europe, real estate, small caps, spinoffs, Telecom, Travel, value | The fund focuses on businesses trading at substantial discounts to intrinsic value, with portfolio companies estimated to trade at just 43% of their intrinsic value in three years. The manager emphasizes buying businesses worth substantially more than their trading price and welcomes volatility as opportunities to invest at better prices. | GLIBA WOSG JDG SEG JET2 GLIBA SEG JET2 |
View |
| 2025 Q3 | Oct 16, 2025 | T. Bailey Multi-Asset Dynamic Fund | 3.8% | - | AAPL, AZN.L, CCC.L, CKN.L, COA.L, HILS.L, IMI.L, INTC, ITRK.L, JDG.L, LRE.L, MSFT, MSLH.L, NVDA, ROR.L, SPI.L, STEM.L, TSCO.L | AI, diversification, emerging markets, fiscal policy, gold, monetary policy, Multi-Asset, risk management | AI-driven rally led by US megacaps shows growing concentration risk. NVIDIA evolved from enabler to financier with $100bn OpenAI investment and $5bn Intel collaboration. Fund managers remain cautious on elevated valuations but confident in transition from overvalued enablers to longer-term AI adoption beneficiaries. | CHRY LN GLDN AU |
View |
| 2025 Q3 | Oct 16, 2025 | T. Bailey Global Thematic Equity Fund | 6.5% | - | AAPL, AZN.L, CCC.L, CKN.L, COA.L, HILS.L, IMI.L, INTC, ITRK.L, JDG.L, LRE.L, MGNS.L, MSFT, MSLH.L, NVDA, ROR.L, SPI.L, STEM.L, TSCO.L | AI, diversification, emerging markets, fiscal policy, gold, healthcare, Multi-Asset, risk management | AI-driven rally led by US megacaps shows growing concentration risk. NVIDIA evolved from enabler to financier, announcing $100bn investment in OpenAI and $5bn in Intel. The AI story entered a new chapter with vendor-financing and leverage replacing innovation as expansion drivers. | CHRY LN |
View |
| 2025 Q4 | Jan 12, 2026 | REQ Global Compounders | 0.0% | 0.0% | ADDTECH-B.ST, APH, BERG-B.ST, BRO, CSU.TO, DPLM.L, GREEN.ST, HEI, HLMA.L, IMCD.AS, INDU-A.ST, JDG.L, LAGR-B.ST, LIFCO-B.ST, LMN.TO, MOMENT.ST, NCAB.ST, NIBE-B.ST, ROKO.ST, ROP, TOI.TO | Acquisitions, AI, Capital Allocation, compounders, Decentralized, long-term, Quality, software | AI narrative has negatively impacted vertical-market software companies, representing 20% of Global fund exposure. Management believes AI poses opportunities rather than uniform threats to VMS, particularly for mission-critical systems with high switching costs. They view trusted incumbents as better positioned to deploy AI effectively than new entrants. Portfolio companies completed 145 acquisitions in 2025, with 70% outside Nordic countries. Companies maintain disciplined approach to M&A with average acquired sales of EUR 12m. Acquisition-driven compounders demonstrate resilience through dual growth engines of organic growth and acquisitions. AI infrastructure build-out has been a clear tailwind for companies exposed to data center expansion. Halma and Diploma benefited from demand for compute, power, cooling, and electrical systems. Amphenol saw robust demand as data-center architectures evolve to support higher power densities. Tariff and trade-related uncertainty under Trump administration affected portfolio companies including IMCD and Judges Scientific. IMCD experienced macroeconomic pressure from tariffs, while policy uncertainty created headwinds for university funding affecting Judges Scientific. | CSU CN BRO JDG LN |
View |
| 2023 Q1 | Apr 30, 2023 | MCJ Capital Partners | 10.6% | 11.7% | CSU.TO, JDG.L, KPG.AX, LIFCO-B.ST | Banking, Business Models, Distribution, global, Housing, international, value | Manager provides extensive analysis of the distributor business model, explaining how distributors thrive in fragmented markets with low purchasing power customers. Discusses threats and defensive strategies, highlighting the model's longevity and transferability across industries. Notes portfolio exposure through Lifco's dental distribution business. | View | |
| 2023 Q4 | Jan 31, 2024 | MCJ Capital Partners | 10.6% | 11.7% | CSU.TO, JDG.L, LIFCO.B.ST | Capital Allocation, international, Serial Acquirers, small caps, value | Manager notes persistent disconnect between large and small company valuations, and international securities relative to S&P 500 counterparts. This valuation gap represents an ongoing opportunity for value-oriented investors. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Fund Letters | Plural Investing | Judges Scientific | Scientific & Technical Instruments | Life Sciences Tools & Services | Bull | New York Stock Exchange | capital allocation, Cooling Systems, Funding Recovery, Niche markets, Research Equipment, scientific instruments, serial acquirer, UK, Vacuum Chambers, Value | View Pitch |
| Apr 28, 2026 | Fund Letters | MCJ Capital Partners | Judges Scientific PLC | Health Care | Life Sciences Tools & Services | Bull | London Stock Exchange | growth, life sciences, Niche markets, scientific instruments, serial acquirer, technology, UK | View Pitch |
| Apr 13, 2026 | Fund Letters | Plural Investing | Judges Scientific | Health Care Equipment & Services | Life Sciences Tools & Services | Bull | London Stock Exchange | capital allocation, decentralized structure, Management Succession, Niche markets, Private Equity Alternative, Research Institutions, scientific instruments, serial acquirer, UK, Universities | View Pitch |
| Nov 2, 2025 | Substack | Compound and Fire | Judges Scientific | Information Technology | Scientific & Technical Instruments | Bull | acquisition-driven growth, consolidator, growth potential, investment choice, Judges Scientific, market position, ROIC, scientific instruments, shareholder-friendly, strategic capabilities | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||